Enabling lung disease patients to be treated at the earliest stage and cured
Optellum has developed the world’s first AI-based Decision Support software to enable physicians to manage lung nodule patients optimally.
Our platform helps clinicians identify and track at-risk patients and speed up decisions for those with cancer while reducing unnecessary procedures.
WHAT WE DO
We are developing an Artificial Intelligence software platform to support clinicians in lung cancer nodule management.
WHO WE ARE
A team of award-winning machine learning, medical device and clinical experts who work with top hospitals, physicians and authors of lung cancer guidelines across Europe and US.
HOW WE DO IT
Optellum and partners have gathered the largest real-world dataset and from this, using Artificial Intelligence and Machine Learning, have developed a solution to enable clinicians to identify at-risk patients and to guide lung cancer management.
Optellum expands its commercial team in readiness for US sales
In recent months, three new appointments have expanded the Optellum team to grow commercial adoption of the Optellum Virtual Nodule Clinic software in the USA. Ryan.
Clinical study demonstrates benefit of Optellum AI-assisted diagnosis for lung cancer
The National Lung Cancer Roundtable (NLCRT) 2020 annual meeting was the latest in a series of conferences that took place virtually in 2020. NLCRT logo NLCRT.